56 related articles for article (PubMed ID: 38509498)
1. Construction and validation of a novel tumor morphology immune inflammatory nutritional score (TIIN score) for intrahepatic cholangiocarcinoma: a multicenter study.
Zhang H; Huang G; Li Q; Wang Y; Yang Z; Chen P; Yuan H; Chen K; Meng B; Yu H
BMC Cancer; 2024 May; 24(1):630. PubMed ID: 38783240
[TBL] [Abstract][Full Text] [Related]
2. Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma.
Xin HY; Zou JX; Sun RQ; Hu ZQ; Chen Z; Luo CB; Zhou ZJ; Wang PC; Li J; Yu SY; Liu KX; Fan J; Zhou J; Zhou SL
J Gastroenterol; 2024 May; 59(5):411-423. PubMed ID: 38461467
[TBL] [Abstract][Full Text] [Related]
3. Tumor burden score and carcinoembryonic antigen predict outcomes in patients with intrahepatic cholangiocarcinoma following liver resection: a multiāinstitutional analysis.
Fu J; Zheng L; Tang S; Lin K; Zheng S; Bi X; Wang J; Guo W; Li F; Wang J; Wang K; Li H; Zeng Y
BMC Cancer; 2024 Mar; 24(1):358. PubMed ID: 38509498
[TBL] [Abstract][Full Text] [Related]
4. Tumor Burden Score Stratifies Prognosis of Patients With Intrahepatic Cholangiocarcinoma After Hepatic Resection: A Retrospective, Multi-Institutional Study.
Li H; Liu R; Qiu H; Huang Y; Liu W; Li J; Wu H; Wang G; Li D
Front Oncol; 2022; 12():829407. PubMed ID: 35330712
[TBL] [Abstract][Full Text] [Related]
5. Albumin-Bilirubin Grade and Tumor Burden Score Predict Outcomes Among Patients with Intrahepatic Cholangiocarcinoma After Hepatic Resection: a Multi-Institutional Analysis.
Munir MM; Endo Y; Lima HA; Alaimo L; Moazzam Z; Shaikh C; Poultsides GA; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Kitago M; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Pawlik TM
J Gastrointest Surg; 2023 Mar; 27(3):544-554. PubMed ID: 36652178
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of HTS grade in patients with intrahepatic cholangiocarcinoma undergoing radical resection: a multicenter study from China.
Huang G; Zhang H; Yang Z; Li Q; Yuan H; Chen P; Xie C; Meng B; Zhang X; Chen K; Yu H
World J Surg Oncol; 2024 Jan; 22(1):17. PubMed ID: 38200585
[TBL] [Abstract][Full Text] [Related]
7. Higher Tumor Burden Status Dictates the Impact of Surgical Margin Status on Overall Survival in Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma.
Endo Y; Sasaki K; Moazzam Z; Lima HA; Alaimo L; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Kitago M; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Pawlik TM
Ann Surg Oncol; 2023 Apr; 30(4):2023-2032. PubMed ID: 36396868
[TBL] [Abstract][Full Text] [Related]
8. Prognosis for intrahepatic cholangiocarcinoma after liver transplantation by size of tumor.
Zeng L; He C; Li X
Surgery; 2023 Oct; 174(4):1094. PubMed ID: 36792459
[No Abstract] [Full Text] [Related]
9. Tumor burden score dictates prognosis of patients with combined hepatocellular cholangiocarcinoma undergoing hepatectomy.
Deng G; Ren JK; Wang HT; Deng L; Chen ZB; Fan YW; Tang YJ; Zhang T; Tang D
Front Oncol; 2022; 12():977111. PubMed ID: 36755864
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of an Ī±-Fetoprotein Tumor Burden Score Model to Predict Postrecurrence Survival among Patients with Hepatocellular Carcinoma.
Ding HF; Yang T; Lv Y; Zhang XF; Pawlik TM;
J Am Coll Surg; 2023 May; 236(5):982-992. PubMed ID: 36744779
[TBL] [Abstract][Full Text] [Related]
11. Combined Tumor Burden Score and Carbohydrate Antigen 19-9 Grading System to Predict Outcomes Among Patients with Intrahepatic Cholangiocarcinoma.
Moazzam Z; Alaimo L; Endo Y; Lima HA; Ruzzenente A; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Cloyd J; Ejaz A; Pawlik TM
J Am Coll Surg; 2023 Apr; 236(4):804-813. PubMed ID: 36728327
[TBL] [Abstract][Full Text] [Related]
12. Preoperative risk score (PreopScore) to predict overall survival after resection for hepatocellular carcinoma.
Endo Y; Lima HA; Alaimo L; Moazzam Z; Brown Z; Shaikh CF; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Shen F; Endo I; Pawlik TM
HPB (Oxford); 2023 Mar; 25(3):353-362. PubMed ID: 36670007
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
